Latest filing published 08 Nov 2023 for Evelo Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Simba Gill: trading record in brief
Simba Gill has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Evelo Biosciences, Inc. and Foghorn Therapeutics Inc. The record holds 10 filings, for trades running from 12 September 2022 to 8 November 2023.
Every open-market trade on record is a sale: 4 sales worth €11k. The rest of the record consists of 5 option exercises. 2023 to date brings no purchases and 4 sales.
The newest entry dates from 8 November 2023: an open-market sale of €53, in Evelo Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Simba Gill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,172 sharesCommon StockSEC:0001694665-23-000176:0
- 15,000 sharesCommon StockSEC:0001694665-23-000160:0
- 1,171 sharesCommon StockSEC:0001694665-23-000135:0
- 3,537 shares@ US$0.1255100.0% of flowCommon StockSEC:0001694665-23-000051:0
- 23,437 sharesCommon StockSEC:0001694665-23-000043:0
- 82,000 shares@ US$0.73100.0% of flowCommon StockSEC:0001562180-22-006673:0
6 of 6 declarations